Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to reduce the severity of infections such as bird flu, and cure chronic conditions ...

November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...

October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in ...

The Democratic Republic of Congo hasn’t reported any new cases of Ebola in the past 10 days at a time the nation is ramping up vaccination efforts to contain the disease. “This is giving some hope in ...

Researchers at Leipzig University and Martin Luther University Halle-Wittenberg have investigated a previously unknown process that occurs during protein synthesis in the cell. They examined how ...

An Ebola outbreak in a southwestern province of the Democratic Republic of the Congo is escalating quickly, as some health responders say they have less than a tenth of the funding needed to contain ...

The U.S. Centers for Disease Control and Prevention has issued a new health advisory about the latest outbreak of Ebola virus disease in the Democratic Republic of Congo. Thirty-seven confirmed cases ...

GOMA, Congo (AP) — As a deadly new Ebola outbreak kills dozens in southern Congo, health authorities and organizations are sounding the alarm, warning they lack the funds and resources to mount an ...

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...